Skip to main content

Table 1 Optimization objectives were set according to prescription dose and predicted fluence generated dose information

From: Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma

ROI name

Objective type

Objective dose (Gy)

Priority

PTV-GTV

Maximum D0%

73.5

70

Minimum D100%

71.5

150

PTV-1-Crop

Maximum D0%

PTV-1’ Px-dose + 3

70

PTV-1

Minimum D100%

PTV-1’ Px-dose

150

PTV-2-Crop

Maximum D0%

PTV-2’ Px-dose + 6

70

PTV-2

Minimum D100%

PTV-2’ Px-dose

150

PTV-LN(L)

Maximum D0%

PTV-LN(L)’ Px-dose + 3

70

Minimum D100%

PTV-LN(L)’ Px-dose + 1.5

150

PTV-LN(R)

Maximum D0%

PTV-LN(R)’ Px-dose + 3

70

Minimum D100%

PTV-LN(R)’ Px-dose + 1.5

150

Brainstem

Maximum gEUD, a = 20

Predicted gEUD × 0.85

50

Brainstem 3 mm

Maximum gEUD, a = 20

Predicted gEUD × 0.85

50

Spinal cord

Maximum gEUD, a = 20

Predicted gEUD × 0.85

50

Spinal cord 3 mm

Maximum gEUD, a = 20

Predicted gEUD × 0.85

50

Left normal parotid

Maximum gEUD, a = 3

Predicted gEUD × 0.75

50

Right normal parotid

Maximum gEUD, a = 3

Predicted gEUD × 0.75

50

Left optic nerve

Maximum gEUD, a = 1

Predicted gEUD

50

Right optic nerve

Maximum gEUD, a = 1

Predicted gEUD

50

Chiasm

Maximum gEUD, a = 1

Predicted gEUD

50

Ring 2 cm

Maximum D1%

Predicted dose × 0.95

50

Maximum D20%

Predicted dose × 0.95

50

Maximum D50%

Predicted dose × 0.95

50

Maximum gEUD, a = 15

Predicted gEUD × 0.95

50

40 Gy-PTV2

Maximum D1%

Predicted dose × 0.95

50

Maximum D20%

Predicted dose × 0.95

50

Maximum D50%

Predicted dose × 0.95

50

Maximum gEUD, a = 10

Predicted gEUD × 0.95

50

  1. Px-dose prescription dose, gEUD generalized equivalent uniform dose